Cargando…
Orabase-Formulated Benzalkonium Chloride Effectively Suppressed Oral Potentially Malignant Disorder In Vitro and In Vivo
[Image: see text] Oral potentially malignant disorder (OPMD) is associated with an increased risk of progression to oral cancer. Patients with dysplastic changes of the precancerous lesions have a higher malignant transformation rate than those without dysplastic changes. Radiotherapy and surgery ar...
Autores principales: | Wang, Yen-Yun, Xiao, Ling-Yi, Chen, Yuk-Kwan, Wu, Pao-Chu, Chen, Yi-Hua, Hu, Stephen Chu-Sung, Yuan, Shyng-Shiou F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114696/ https://www.ncbi.nlm.nih.gov/pubmed/32258937 http://dx.doi.org/10.1021/acsomega.0c00640 |
Ejemplares similares
-
Comparison of the Efficacy of Topical Triamcinolone in Orabase and Curcumin in Orabase in Oral Graft-Versus-Host Disease
por: Mansourian, Arash, et al.
Publicado: (2017) -
Oral florid papillomatosis: Topical treatment with 5% imiquimod in orabase
por: Ruiz‐Huertas, Pedro, et al.
Publicado: (2022) -
Aspergilli Response to Benzalkonium Chloride and Novel-Synthesized Fullerenol/Benzalkonium Chloride Nanocomposite
por: Unković, Nikola, et al.
Publicado: (2015) -
Innovation of natural essential oil-loaded Orabase for local treatment of oral candidiasis
por: Labib, Gihan S, et al.
Publicado: (2015) -
Benzalkonium Chloride Suppresses Rabbit Corneal Endothelium Intercellular Gap Junction Communication
por: Zhang, Zhenhao, et al.
Publicado: (2014)